Associated Papers
A genetically defined signature of responsiveness to erlotinib in early-stage pancreatic cancer patients: Results from the CONKO-005 trial.
Hoyer K et al.
Ebiomedicine, 2021
33862582 (PubMed )
Supplement: mmc3.xlsx › S5
Deep sequencing of uveal melanoma identifies a recurrent mutation in PLCB4.
Johansson P et al.
Oncotarget, 2016
26683228 (PubMed )
Supplement: oncotarget-07-4624-s002.xlsx › Sheet1
Select a paper to view details